USP

PRESS RELEASE Rockville, MD, July 11, 2023 – The U.S. Pharmacopeia (USP) and The National Institute for Pharmaceutical Technology and Education...

USP has launched the newest tool in their suite of solutions to address the evolving nitrosamines crisis: the Nitrosamines Analytical...

In industrial practice, the development of pharmaceutical dry granulation processes typically involves time- and resource-intensive multivariate experiments. These experiments are...

Through the World Health Organization, ten international pharmacopeias—including USP—have collaborated to publish this interactive dashboard of active pharmaceutical ingredients and...

USP is interested in hosting a Virtual Round Table concerning the modernization of this monograph. We encourage all to participate...

The COVID19 pandemic is testing global medical supply chains. Read the new US Pharmacopeia paper on Pandemic Preparedness for Regulators...

Do you want to use the USP Pending Monograph process? Or have you ever wondered what the USP Pending Monograph...

Article By Dr. Catherine Sheehan - Senior Director of Science – Excipients at the United States Pharmacopeial Convention With significant innovations...